| Literature DB >> 35527904 |
Krisana Peewasan1, Marcel P Merkel2, Kristof Zarschler3, Holger Stephan3, Christopher E Anson1, Annie K Powell1,2.
Abstract
Tetranuclear chiral Cu(ii)-Schiff-base complexes S-1 and R-1, were synthesised using enantiomerically pure (S)-(H2vanPheol) and (R)-(H2vanPheol) ligands respectively in the ratio of 1 : 1 of Cu(NO3)2 to (S/R)-(H2vanPheol) in MeOH at room temperature. A pair of polynuclear chiral Cu(ii)-cluster complexes were characterized using single-crystal X-ray diffraction, elemental analysis, infrared and CD spectroscopy. The results revealed the importance of these chiral ligands encouraging the arrangement of copper metal in non-centrosymmetric polar packing. The potential of the novel [Cu4(S/R-vanPheol)2(S/R-HvanPheol)2(CH3OH)2](NO3)2 complexes as biologically active compounds was assessed in particular regarding their anti-proliferative and anti-microbial properties. This journal is © The Royal Society of Chemistry.Entities:
Year: 2019 PMID: 35527904 PMCID: PMC9069531 DOI: 10.1039/c9ra03586a
Source DB: PubMed Journal: RSC Adv ISSN: 2046-2069 Impact factor: 4.036
Scheme 1Preparation of Schiff-bases (S)/(R)-(H2vanPheol).
Crystallographic data of complexes S-1 and R-1
| S-1 | R-1 | |
|---|---|---|
| Empirical formula | C71H82Cu4N6O21 | C70.7H80.8Cu4N6O21 |
| Formula weight | 1609.58 | 1604.77 |
| Temperature/K | 180(2) | 180.15 |
| Crystal system | Monoclinic | Monoclinic |
| Space group |
|
|
|
| 10.6198(7) | 10.5835(8) |
|
| 21.4213(14) | 21.529(2) |
|
| 15.6347(12) | 15.5711(12) |
|
| 90 | 90 |
|
| 94.833(6) | 94.696(6) |
|
| 90 | 90 |
| Volume [Å3] | 3544.1(4) | 3536.0(5) |
|
| 2 | 2 |
|
| 1.508 | 1.507 |
|
| 1.263 | 1.266 |
|
| 1668 | 1662 |
| Crystal size [mm3] | 0.34 × 0.18 × 0.16 | 0.58 × 0.23 × 0.18 |
| Radiation | MoKα ( | MoKα ( |
| 2 | 3.232 to 53.462 | 3.784 to 52.742 |
| Index ranges | −13 ≤ | −11 ≤ |
| Reflections collected | 29 165 | 28 025 |
| Independent reflections | 14 517 [ | 14 367 [ |
| Data/restraints/parameters | 14 517/29/940 | 14 367/34/935 |
| Goodness-of-fit on | 0.938 | 0.978 |
| Final | 0.0380 | 0.0431 |
| Final w | 0.0936 | 0.1200 |
| Largest diff. peak/hole [e Å−3] | 0.53/−0.62 | 0.73/−0.63 |
| Flack parameter | −0.010(7) | −0.003(15) |
Fig. 1The structures of S-1 and R-1. The hydrogen atoms and nitrate counterions are omitted for clarity. Hydrogen bonds are shown as green dashed lines. Colour codes for the atoms: light blue (Cu), blue (N), red (O) and black (C).
Fig. 2CD spectra of 50 μM solution of S-1 and R-1 in MeOH.
Fig. 3In vitro viability evaluation of A431 and HEK293 cells after treatment with S-1 and R-1 for 48 h. The cellular metabolism was determined as a measure of viability using a MTS assay. The percentage of cell viability is expressed relative to vehicle-treated control cells that were treated with the corresponding concentration of DMSO (final concentration 0.4%).
IC50 values after incubation of A431 and HEK293 cells with S-1 and R-1 for 48 h
| IC50 [μM] | ||
|---|---|---|
| A431 | HEK293 | |
| S-1 | 45.28 ± 10.21 | 13.47 ± 1.97 |
| R-1 | 39.16 ± 7.95 | 12.10 ± 1.57 |
| Cisplatin | 7.8 ± 7.95 | 8.1 ± 7.95 |
Fig. 4Cell densities measured at a wavelength of 600 nm (OD600) during cultivation of Gram-positive B. subtilis in the presence of 10 μM (circle), 50 μM (rhombus) or 100 μM (square) of S-1 (A) and R-1 (B), respectively.